Ankylose This! Living with Ankylosing Spondylitis

Saturday, June 25, 2005

Arcoxia better than naproxen?

A recent, year-long study concluded that Arcoxia (etoricoxib), a COX-2 inhibitor, was more effective than naproxen in treating ankylosing spondylitis (via SAA). As a naproxen user, you have my attention. But in the wake of all the brouhaha regarding COX-2s, Arcoxia has yet to receive FDA approval; the agency wants more data from Merck before it will consider the drug.

Comments on this post

  • Mike H here.
    I've been prescribed, in Feb 2005, ARCOXIA by my new Rheumatologist. I should be on the new anti-TNF treatment, but NICE have cancelled their funding for we Anky Spons.
    I find ARCOXIA to ease the general stiffness and to improve overall flexibility of the lower spine and hips. It allows for me to get greater movements whilst doing my pool exercises. However, my BP has risen. Hopefully, it'll improve my stomach/bowel problems over time.
    I have had raised BP for the last 3 years or so (145/95) and it went up to 150/100. Accordingly, I've reduced the Arcoxia dosage from 120mg to 90mg and monitoring my own BP at home twice weekly. My rheumatologist is of the opinion that Arcoxia is not contributing to the BP rise. Other reason's exist. My BP medication probably needs updating.

    Posted by Blogger Mike H (7/03/2005 12:28 PM)  

Post a Comment

Links to this post

Create a Link